JP Morgan Chase’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,070
| Closed | -$4.12K | – | 7770 |
|
|
2026
Q1 | $4.12K | Sell |
2,070
-856
| -29% | -$1.66K | ﹤0.01% | 6914 |
|
|
2025
Q4 | $4.48K | Buy |
2,926
+1,387
| +90% | +$2.3K | ﹤0.01% | 6826 |
|
|
2025
Q3 | $2.26K | Buy |
1,539
+193
| +14% | +$287 | ﹤0.01% | 6890 |
|
|
2025
Q2 | $2.4K | Sell |
1,346
-3,345
| -71% | -$4.96K | ﹤0.01% | 6514 |
|
|
2025
Q1 | $6.85K | Sell |
4,691
-7,410
| -61% | -$14.5K | ﹤0.01% | 6383 |
|
|
2024
Q4 | $18.5K | Sell |
12,101
-55,384
| -82% | -$90.1K | ﹤0.01% | 6268 |
|
|
2024
Q3 | $122K | Sell |
67,485
-113,287
| -63% | -$207K | ﹤0.01% | 5616 |
|
|
2024
Q2 | $304K | Buy |
180,772
+109,640
| +154% | +$228K | ﹤0.01% | 4935 |
|
|
2024
Q1 | $184K | Buy |
71,132
+48,438
| +213% | +$113K | ﹤0.01% | 5397 |
|
|
2023
Q4 | $44.9K | Buy |
22,694
+22,688
| +378,133% | +$19.8K | ﹤0.01% | 6028 |
|
|
2023
Q3 | $6 | Buy |
+6
| New | +$7 | ﹤0.01% | 7341 |
|
|
2022
Q4 | – | Sell |
-211,311
| Closed | -$139K | – | 6582 |
|
|
2022
Q3 | $139K | Buy |
211,311
+49,926
| +31% | +$70.5K | ﹤0.01% | 5129 |
|
|
2022
Q2 | $299K | Sell |
161,385
-135,725
| -46% | -$293K | ﹤0.01% | 4860 |
|
|
2022
Q1 | $957K | Buy |
297,110
+130,564
| +78% | +$441K | ﹤0.01% | 4305 |
|
|
2021
Q4 | $716K | Sell |
166,546
-13,283
| -7% | -$71.9K | ﹤0.01% | 4610 |
|
|
2021
Q3 | $1.07M | Sell |
179,829
-28,789
| -14% | -$193K | ﹤0.01% | 4255 |
|
|
2021
Q2 | $1.73M | Sell |
208,618
-49,806
| -19% | -$404K | ﹤0.01% | 3899 |
|
|
2021
Q1 | $2.22M | Buy |
258,424
+200,308
| +345% | +$2.22M | ﹤0.01% | 3642 |
|
|
2020
Q4 | $703K | Sell |
58,116
-59,200
| -50% | -$817K | ﹤0.01% | 4171 |
|
|
2020
Q3 | $1.92M | Sell |
117,316
-6,139
| -5% | -$101K | ﹤0.01% | 3265 |
|
|
2020
Q2 | $1.85M | Buy |
+123,455
| New | +$1.67M | ﹤0.01% | 3155 |
|
|
2020
Q1 | – | Sell |
-30,572
| Closed | -$182K | – | 5334 |
|
|
2019
Q4 | $182K | Buy |
+30,572
| New | +$157K | ﹤0.01% | 4709 |
|
|
2018
Q3 | – | Sell |
-50,297
| Closed | -$166K | – | 5672 |
|
|
2018
Q2 | $166K | Buy |
+50,297
| New | +$189K | ﹤0.01% | 4643 |
|
|
2017
Q4 | – | Sell |
-295
| Closed | -$1K | – | 5441 |
|
|
2017
Q3 | $1K | Sell |
295
-7,864
| -96% | -$27.3K | ﹤0.01% | 4901 |
|
|
2017
Q2 | $31K | Buy |
+8,159
| New | +$33.9K | ﹤0.01% | 4441 |
|
Other funds holding CGEN
SCM
NAMI
TFCM
AIM
AS
AI
JP Morgan Chase's CGEN Position: Q2 2026 in Review
JP Morgan Chase sold out of Compugen (CGEN) in Q2 2026, closing a stake of 2,070 shares — an estimated $4.12K sold.
JP Morgan Chase first reported a position in CGEN in Q2 2017 and held it in 25 quarters. The position peaked at $2.22M in Q1 2021. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.
- JP Morgan Chase reported no remaining Compugen position as of Q2 2026 after selling out during the quarter.
- JP Morgan Chase sold 2,070 Compugen shares in Q2 2026, an estimated $4.12K.
- JP Morgan Chase first reported a position in Compugen in Q2 2017 and held it in 25 quarters.
- JP Morgan Chase's Compugen position peaked at $2.22M in Q1 2021.
- 82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.